Rebalix
Logo LGIMLGIM · sheet of 10 September 2026
ETF sheet · official issuer and register data

L&G FTSE 100 Leveraged (Daily 2x) UCITS ETF

LUK2 · IE00B4QNJJ23 · class GBP Acc. · GBP · domicile Ireland
Equity · United Kingdom · Large capleveraged 2xSFDR art. 6 (inferred)
Index tracked: FTSE 100® Daily Leveraged Index Net TR GBP
TER
0.50%+ trans. 0.01%
Fund size
24 m EUR
Tracking difference
not computable
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Accumulating
Launch 18 Jun 2009 · costs from the KID as of 2 Sept 2026 · 0 securities held · 1 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The investment objective of the Fund is to track the performance of the FTSE 100® Daily Leveraged Index. The Fund is passively managed and aims to track the performance of the FTSE 100® Daily Leveraged Index (the “Index”), before the deduction of fees and expenses. The Index is designed to provide daily investment results that correspond to twice the daily performance of the FTSE 100® Net Dividend Total Return Index (the “Underlying Index”), adjusted to reflect financing and borrowing costs. Due to the daily rebalancing of the Index, the Fund’s performance…

Performance since series start (in euro) — base 100

29 Jul 201631 Jul 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
2017201920212023202527957279
High 279 (28 Jul 2026) · low 57 (23 Mar 2020) · last 279. Past performance is not indicative of future results.

Returns in euro

1 year+39.3%
3 years+88.5%
5 years+130.1%
10 years+179.0%
Since series start+179.0%

Risk · 1 / 3 / 5 years

Volatility (ann.)22.21%22.10%24.70%
Max drawdown−17.58%−25.28%−25.28%
Sharpe1.320.970.66
Sortino1.951.360.91
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LUK2 · IE00B4QNJJ231
RebalixLUK2 · IE00B4QNJJ23 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: daily-reset leveraged/inverse product: yearly TD does not measure replication

Holdings

Portfolio as declared by the issuer · 30 Jun 2026 · 0 securities · top-10 weight = 49.5%
Top holdingsWeight
HSBC10.5%
Shell7.4%
AstraZeneca7.3%
Rolls-Royce4.8%
Unilever3.9%
British American Tobacco3.6%
BP3.4%
GSK3.0%
Rio Tinto2.9%
Barclays2.7%
Countries (% of fund)
Regno Unito100.0%
Sectors (% of fund)
Finanziari27.3%Beni di consumo primari14.0%Industriali13.7%Assistenza sanitaria12.1%Energia10.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
ETLD · Börse Düsseldorf
+ 3 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · fundcentres.landg.com/srp/documents-id/cf0586d4-e23f-4fba-8ebb-5920dc1
Factsheet · fundcentres.landg.com/srp/documents-id/c50ab8eb-75c5-4c36-aac4-bc2daec
Prospectus · fundcentres.landg.com/srp/lit/7qeQjP/Prospectus_Legal-General-UCITS-ET
The live sheet, always up to date
rebalix.com/en/etf/IE00B4QNJJ23
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · LUK2 · IE00B4QNJJ232